We have located links that may give you full text access.
ENGLISH ABSTRACT
JOURNAL ARTICLE
[Fibrinolysis in pregnancy toxemia].
Nihon Sanka Fujinka Gakkai Zasshi 1983 December
Pathogenesis of toxemia of pregnancy has been studied of late in terms of coagulation and fibrinolysis, and the results show evidence of hypercoagulability but not of fibrinolysis which has remained unclarified. Our study aims to elucidate the fibrinolytic kinetics of toxemia in normal pregnant women divided into mild and severe types and eclampsia, and also to study changes in the coagulation and fibrinolytic system in toxemia given urokinase. In the affected group the following 1)--3) parameters characteristics were more significant than in other groups. 1) Decreased platelet count. 2) Prolonged ELT. 3) Increased AT-III. 4) There was no significant difference between the groups examined in PT, APTT, Fbg., serum FDP, alpha 2-antipl., alpha 1-AT, alpha 2-MG, C1-INA, and plg. 5) Signs in eclampsia, with region slightly distributed, tended to resemble those in the serious group. 6) alpha 2-antipl., and alpha 1-AT in the case given urokinase tended to decrease. 7) There was observed a case of accelerating and lowering fibrinolysis that appeared simultaneously with the following signs: decreased alpha 2-antipl., increased serum FDP, and prolonged ELT; and also the case whose signs widely changed even after a relatively small dose of urokinase. The results obtained suggest the possibility of variable fibrinolytic kinetics.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app